Inside the dealmaking that pushed Trump to reclassify pot, expand access
Why it matters
The Trump administration has reclassified pot and expanded access to CBD products, following a year-long industry push that combined lobbying, donations, and insider access. This move opens the door to a Medicare CBD pilot program. The dealmaking process suggests a significant shift in the US government's stance on cannabis.
Expected market reaction
Market impact analysis based on bullish sentiment with 68% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 24855
Original source
Trump’s pot executive order follows a yearlong industry push blending lobbying, donations and insider access, opening the door to a Medicare CBD pilot.
Original article published by CNBC on December 20, 2025. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
Llama 3.1 8B Instant (Groq) · 37.9% correct across 177 scored calls on equities See the full record